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A method for the binding of virus to a silica gel thin-layer chromatogram is presented. After development 
the chromatogram is overlayed with the ‘Z51-labelled virus and the bound virus is autoradiographed. 
Alternatively, the unlabelled virus may be detected after exposure to monoclonal antibody and labelled 
anti-antibody. The Sendai virus strain used did not bind to brain gangliosides earlier proposed to be 
receptors, but bound to human erythrocyte gangliosides. This finding may be explained by the existence 
of Sendai virus variants with different receptor specificities. 
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1. INTRODUCTION 
The initial stage in infections with viruses is their 
interaction with receptors on the host cell surface 
[l]. Host and tissue specificities displayed by dif- 
ferent viruses may in part be explained by a selec- 
tion at the receptor level [2]. Progress in the 
chemical identification of receptors has been 
relatively slow, mainly due to the lack of adequate 
techniques for the handling of solubilized am- 
phipathic membrane components [3]. Also, tradi- 
tional inhibition studies based on solubilized 
univalent receptors or receptor analogues may not 
necessarily reveal a specific virus-cell interaction 
based on multivalent low-affinity sites [3]. This 
problem has been overcome by using lipid vesicles 
as carriers for receptor preparations [3,4] or plastic 
microtiter wells to which receptors have been 
hydrophobically adsorbed from solution [3,5]. We 
have now extended the solid phase approach 
employing a binding of virus particles to a thin- 
layer chromatogram on which one group of recep- 
tor candidates, the glycosphingolipids, has been 
separated. In this way a particular receptor 
glycolipid may be specifically detected in a mixture 
extracted by organic solvent from a target cell. 
Sendai virus was chosen as a first object of study 
since brain gangliosides with the partial sequence 
NeuAccu2-+8NeuA~2-3Ga&31-+3GalNAc 
have been shown both to bind the virus [4,5] and 
promote the infection [6]. 
2. MATERIALS AND METHODS 
* To whom correspondence should be addressed 
The Z strain of Sendai virus earlier used for im- 
munological studies [7] was grown in embryonated 
eggs. About 5 x 10’ purified virions (about 2 mg 
protein) were labelled with “‘1 in two equal por- 
tions using 250 ~1 each of 50,&i Bolton-Hunter 
reagent [8] delivered by New Engand Nuclear. The 
labelled preparation was dialyzed at room 
temperature against 500 ml of phosphate-buffered 
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saline of pH 7.3 (PBS) for two days with two 
changes of buffer. The final volume of 0.5 ml was 
diluted with 9.5 ml PBS and had a total radioac- 
tivity of 3 x lo6 cpm. Most of the non-acid 
glycolipid preparations used have been described 
elsewhere [9- 131. Ganglioside fractions of human 
brain and human erythrocytes were prepared with 
standard methods [ 141. 
Virus binding to glycolipids was performed on 
plastic-treated thin-layer plates as first used for 
antibody-binding [ 151 and later modified [ 161. 
Glycolipids (20-40 pg in each lane) were separated 
on aluminum sheets coated with silica gel 
60 (Merck) using chloroform/methanol/water 
(60:35:8, by vol.) for non-acid (fig.la,b) and 
chloroform/methanol/2.5 M ammonia (60 : 40 : 9, 
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by vol.) for acid glycolipids (fig. lc,d). 
Anisaldehyde reagent was used for chemical detec- 
tion [17]. For virus binding the dried 
chromatogram with separated glycolipids was dip- 
ped for 1 min in 200 ml of diethylether containing 
0.5% (w/v) of polyisobutylmethacrylate (Plex- 
igum P28, Rohm, GmbH, Darmstadt) and dried 
for 2 min. The plate was then sprayed with PBS 
containing 2% bovine serum albumin (BSA) and 
0.1% NaN3 (solution A) and then immersed in 
solution A and placed in a Petri dish for 2 h. After 
tipping off solution A the labelled virus prepara- 
tion was added (0.5 ml for each lane of about 
5 mm width) to the chromatogram placed horizon- 
tally in a humidified atmosphere of a Petri dish. 
After incubation for 2 h the virus suspension was 
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Fig.1. Thin-layer chromatogram after detection with anisaldehyde (a) and autoradiogram (b) after binding of “‘I- 
labelled Sendai virus, using for both (a) and (b) 20-40pg total neutral glycolipids of the following sources: human 
erythrocytes of blood group A (lane l), monkey intestine of species Macacca cynomolgus (lane 2), human meconium 
of blood group A (lane 3), human meconium of blood group B (lane 4), rat small intestine (lane 5), rabbit small intestine 
(lane 6), guinea pig small intestine (lane 7) and dog small intestine (lane 8). The thin-layer chromatogram in (c) after 
detection with anisaldehyde and the autoradiogram in (d) after detection of unlabelled virus with monoclonal antibody 
used 30 pg of total gangliosides of human erythrocytes (lane 1) and 15 fig of total gangliosides of human brain (lane 
2). The figures to the left of chromatogram (a) indicate the number of sugars in the neutral glycolipid bands detected. 
For the identity of the major ganglioside bands in fig.lc, lanes 1 and 2, the reader may consult 1181 and [14], 
respectively. In fig.lc and d, lane 2, there is a rapid-moving glycolipid with double spot appearance which binds the 
virus. This is a small contamination of galactosylceramides in the brain ganglioside sample, being a positive control 
of binding (cf. a and b). 
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tipped off and the plate was washed 6 times with 
PBS, 1 min each time. The plate was dried and ex- 
posed at room temperature for 137 h to XAR-5 X- 
ray film (Eastman) using an intensifying screen. 
For detection of the unlabelled virus with 
monoclonal antibody incubation was done for 2 h 
with antibody 817 [7] produced in ascites and 
diluted 1: 100 with solution A, using about 0.5 ml 
for each chromatographic lane. After washing 5 
times with PBS rabbit anti-mouse Fab (‘*?- 
labelled F(ab’)z, about 4 x 10’ cpm/ml in solution 
A) was added for 2 h followed by 6 washings with 
PBS, drying of the plate and exposure to X-ray 
film (161. 
3. RESULTS 
Fig. 1 documents the autoradiograms after bind- 
ing of radiolabelled virus to neutral (non-acid) 
glycolipids (b) and unlabelled virus to ganglio- 
side fractions (d). Unexpectedly, there was no 
detectable binding to the ganglioside frac- 
tion from human brain (fig.ld, lane 2). This 
fraction was a total ganglioside mixture (see 
fig.lc, lane 2 for chemical detection), which 
contained molecular species with the 
sequences NeuAccu2--+3GalPl-3GalNAc or 
NeuAccY2 - 8NeuAccu2 - 3Ga@l- 3GalNAc 
[ 141 shown before to bind the virus and mediate in- 
fection [4-61. On the other hand the virus bound 
strongly to slow-moving species of total 
gangliosides of human erythrocytes (fig. Id, lane 1) 
known to contain N-acetylneuraminic acid at- 
tached to Gal,& -4GlcNAc structures [181. Also, 
there was an apparently avid binding to neutral 
glycolipids with 1, 2 and 3 sugars but not to some 
major glycolipids with more than 3 sugars (fig.lb, 
which may be compared to the same lanes after 
chemical detection, shown in la). There was a 
preference of binding to glycolipids with 
phytosphingosine or 2-hydroxy fatty acid in the 
lipophilic part, which migrate relatively slower 
than their less hydroxylated counterparts. This is 
evident from comparison of the 2- and 3-sugar 
regions, respectively, of separate lanes. The human 
erythrocyte sample (lane 1) did not bind and has 
rapid-moving species with mostly sphingosine and 
non-hydroxy fatty acid. On the other hand the in- 
testinal samples showed binding and have slow- 
moving species due to phytosphingosine and 
2-hydroxy fatty acid, as shown in lane 5 for rat 
[ 1 I], lane 6 for rabbit [9,12], lane 7 for guinea pig 
[9] and lane 8 for dog [ 131. The specificity of bind- 
ing concerning both the lipophilic part and car- 
bohydrate structure has been worked out in detail 
using pure glycolipids (in preparation). 
4. DISCUSSION 
By treating a silica gel thin-layer plate with 
polyvinylpyrrolidone (PVP), protein ligands in the 
form of cholera toxin [ 191 or monoclonal an- 
tibodies [20] may be used in an overlay technique 
to study specific binding to glycolipids. An im- 
proved procedure has used plastic instead of PVP 
in order to define glycolipid epitopes in the interac- 
tion with monoclonal antibodies (see [15,16]). The 
role of the plastic coating may primarily be to pro- 
vide a hydrophobic film from which the am- 
phipathic glycolipids present their hydrophilic 
oligosaccharides with similarity to the natural cell 
membrane. Unspecific hydrophobic binding is 
prevented by final coating with BSA. 
The present application to virus binding was in- 
itiated with Sendai virus because certain brain 
gangliosides are known to bind the virus with high 
affinity [4-61. Our failure when first using the ‘*‘I- 
labelled virus to detect virus binding to these 
glycolipids in our assay, although using large 
amounts of both virus and gangliosides, may in- 
dicate that the assay conditions were not ap- 
propriate. Although unlikely, the labelling reagent 
may have altered the binding site of the virus 
hemagglutinin. We therefore used unlabelled virus 
and detected the virus with monoclonal antibody 
[7], with the same result (fig.ld, lane 2). However, 
there was an apparently high-avidity binding to 
certain gangliosides of human erythrocytes (fig. Id, 
lane 1) which differ in composition from brain 
species (see [14,18]). We are at present isolating 
these gangliosides for precise structure analysis. 
The finding of virus binding to erythrocyte 
gangliosides but not to brain gangliosides may be 
explained by the existence of variants of Sendai 
virus with distinct receptor specificities. This is not 
unlikely, in view of the recently reported selection 
of influenza virus variants with specificity for 
NeuAm2--+3Gal and NeuAccu2-+6Gal, respec- 
tively [21]. Also, a Sendai virus preparation was 
reported in [22] as unable to bind brain 
17 
Volume 170, number 1 FEBS LETTERS May 1984 
gangliosides using an earlier described liposome 
assay which had demonstrated a strong binding 
]41. 
The binding of the virus to neutral glycolipids 
with l-3 sugars was shown both with radiolabelled 
ligand (fig.1 b, after long exposure due to low ex- 
ternal labelling) and after detection with antibody 
(not shown). After these experiments had been per- 
formed we learned about the results in [23] on the 
inhibition of myxovirus-induced hemolysis by 
some natural and synthetic simple glycolipids. A 
second binding site on the virus was postulated, 
recognizing Gal-terminating glycolipids. We may 
have detected the same postulated site by our direct 
binding assay. 
The approach illustrated here is considered to be 
very potent for the detection of glycolipid-based 
receptors of viruses in general. Mixtures of poten- 
tial receptors extracted from target tissues are 
preseparated in the assay medium and presented 
on a membrane-like surface. This solid-phase 
multivalency of receptors should also reveal low- 
affinity binding sites of interest [3] in spite of shear 
forces produced by the washing steps. The 
chromatographic preseparation of glycolipids also 
exposes and enables binding to very minor 
glycolipids that may be difficult to detect in mixed 
micelles. Although total lipid extracts including 
membrane lipids may be applied on the plate we 
prefer the use of purified total acid or non-acid 
glycolipids for a screening since one may for iden- 
tification purposes directly compare the 
autoradiogram with chemically detected patterns 
(fig.1). Use of many tissue samples in one assay, 
different qualitatively and quantitatively, covers a 
very large number of receptor candidates. 
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